BridgeBio Pharma, Inc. (BBIO) vs Denali Therapeutics Inc. (DNLI)
Detailed comparison between BridgeBio Pharma, Inc., Denali Therapeutics Inc..Total Return (%)
BridgeBio Pharma, Inc. (BBIO)Denali Therapeutics Inc. (DNLI)
Which stock do you think will perform better?
BridgeBio Pharma, Inc.
BBIO
Denali Therapeutics Inc.
DNLI
| Metric | BridgeBio Pharma, Inc. (BBIO) | Denali Therapeutics Inc. (DNLI) |
|---|---|---|
| Current Price | $51.96 | $14.52 |
| Change | 1.91 (3.82%) | 0.57 (4.09%) |
| Market Cap | $9.93B | $2.12B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -16.98 | -5.28 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $54.60 | $33.33 |
| 52-Week Low | $21.72 | $10.57 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-4.29 | $-2.92 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| BBIO | 3.92% | 51.89% | 109.52% | 31.21% | 88.60% | 88.60% |
| DNLI | -6.02% | -37.68% | -49.35% | -60.64% | -32.31% | -32.31% |